← back to search

John J. Moore

UNSW Sydney · AU
Area of research
Mechanics of Materials · Materials Chemistry
Research interest
Research interests include Medicine, Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Stem cell, and Idarubicin.
h-index
citations
1,372
works
13
NIH funding
primary concept
email

Recent publications

Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin
New England Journal of Medicine 2025cited by 47position: middledoi
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
Bone Marrow Transplantation 2025cited by 5position: middledoi
Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey
BMC Psychology 2023cited by 7position: middledoi
Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey
Clinical Nursing Research 2023cited by 4position: middledoi
Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey
Journal of Cancer Survivorship 2021cited by 13position: middledoi
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Bone Marrow Transplantation 2019cited by 61position: middledoi
Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Bone Marrow Transplantation 2019cited by 1position: middledoi
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry 2018cited by 95position: firstdoi
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
The Lancet Oncology 2015cited by 359position: middledoi
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
The Lancet Haematology 2015cited by 166position: middledoi
Does ex vi vo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
Bone Marrow Transplantation 2015cited by 54position: middledoi
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
The Lancet Infectious Diseases 2013cited by 221position: middledoi
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Blood 2012cited by 339position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Hertzberg · Australasian Leukaemia and Lymphoma Group5 papers (2012–2023)David Gottlieb · The University of Sydney4 papers (2021–2025)Nicole Gilroy · The University of Sydney4 papers (2013–2023) · 3 papers (2021–2023)Jeff Szer · The Royal Melbourne Hospital3 papers (2012–2015)Megan Hogg · Westmead Hospital3 papers (2021–2023)Matthew Greenwood · The University of Sydney3 papers (2021–2023)John Reynolds · Monash Medical Centre3 papers (2012–2025)Gemma McErlean · University of Wollongong3 papers (2021–2023)Lisa Brice · Royal North Shore Hospital3 papers (2021–2023) · 3 papers (2021–2023)Gillian Huang · Westmead Hospital3 papers (2021–2023) · 3 papers (2021–2023)Dominique Farge · Maine Farmland Trust2 papers (2015–2025)Harry Iland · The University of Sydney2 papers (2012–2015) · 2 papers (2012–2015)Jörg Henes · University Clinical Centre2 papers (2015–2025) · 2 papers (2012–2015)Maria Carolina Oliveira · University of South Florida2 papers (2015–2025) · 2 papers (2012–2015)